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The Effects of Host Age on the Transport of Complement-Bound
Complexes to the Spleen and the Pathogenesis of Intravenous
Scrapie Infection
Karen L. Brown, Anton Gossner, Simon Mok, and Neil A. Mabbott
The Roslin Institute and Royal (Dick) School of Veterinary Sciences, University of Edinburgh, Roslin, Midlothian, United Kingdom
Infections with variant Creutzfeldt-Jakob disease (vCJD) have almost exclusively occurred in young patients, but the reasons for
this age distribution are uncertain. Our data suggest that the pathogenesis of many peripherally acquired transmissible spongi-
form encephalopathy (TSE) agents is less efficient in aged individuals. Four vCJD cases linked to transfusion of vCJD-
contaminated blood or blood products have been described. Three cases occurred in elderly patients, implying that intravenous
exposure is more efficient in aged individuals than other peripheral routes. To test this hypothesis, young (6 to 8 weeks old) and
aged (600 days old) mice were injected intravenously with a TSE agent. In aged and youngmice, the intravenous route was more
efficient than other peripheral routes of TSE agent exposure. However, in agedmice, disease pathogenesis was significantly re-
duced. Althoughmost aged mice failed to develop clinical disease during their life spans, many showed histopathological signs of
TSE disease in their brains. Thus, the effects of age on intravenous TSE pathogenesis may lead to significant levels of subclinical
disease in the population. After peripheral exposure, many TSE agents accumulate upon follicular dendritic cells (FDCs) in lym-
phoid tissues before they infect the brain. In aged spleens, PrPC expression and TSE agent accumulation upon FDCs were re-
duced. Furthermore, the splenic marginal zone microarchitecture was substantially disturbed, adversely affecting the delivery of
immune complexes to FDCs. This study is the first to suggest that the effects of aging on the microarchitecture and the function
of the splenic marginal zone significantly influence the pathogenesis of an important pathogen.
Transmissible spongiform encephalopathies (TSEs) (prion dis-eases) are subacute neurodegenerative diseases affecting both
humans and animals. These diseases are defined by a number of
characteristic pathological changes in the central nervous system
(CNS), including vacuolation of the neuropil, gliosis, and aggre-
gations of PrPSc, an abnormally folded isoform of the cellular
prion protein (PrPc). The precise nature of the TSE agent is un-
certain, but PrPSc is considered to constitute themajor, if not sole,
component of the infectious agent (27). Infectious, sporadic, and
familial forms of humanTSE disease have been identified. Follow-
ing peripheral exposure to many natural and experimental TSEs,
including natural scrapie in sheep (1), chronic wasting disease
(CWD) in cervids (45), and variant Creutzfeldt-Jakob disease
(vCJD) in humans (19), early agent accumulation occurs upon
follicular dendritic cells (FDCs) within the secondary lymphoid
tissues prior to the spread of infection to the CNS (termed “neu-
roinvasion”). The accumulation of TSE agents upon FDCs is a
critical stage in the neuroinvasion process as disease susceptibility
is reduced in their absence (32, 34, 39).
Dietary exposure to bovine spongiform encephalopathy
(BSE)-contaminated meat products is considered the most likely
source of vCJD in humans (5). In the United Kingdom, most
clinical cases of vCJD have occurred almost exclusively in young
adults (median age at onset of disease, 26 years; median age at
death, 28 years) (40). These data starkly contrast those for spo-
radic CJD cases, which have predominantly occurred in the el-
derly (median age at onset of disease, 67 years) (40). The factors
responsible for the age-related incidence of vCJD are not known as
the suggestion that this is simply due to exposure to greater levels
of BSE through dietary preference is unproven (2). Data from
experimental mouse models show that the underdeveloped or re-
duced functional status of FDCs in either very young (neonatal) or
aged mice significantly impairs TSE neuroinvasion following in-
traperitoneal (i.p.) or oral exposure (4, 21, 42). This implies that
the pathogenesis ofmany acquired TSE infections which accumu-
late in lymphoid tissues prior to neuroinvasion, including natural
sheep scrapie, CWD, and vCJD, may likewise be much less effi-
cient in the aged.
In the United Kingdom, four cases of vCJD have been reported
in recipients of blood or blood products derived from vCJD-
infected donors (18, 28, 43, 48). In contrast to the overwhelming
majority of the clinical vCJD cases considered to be acquired
through dietary exposure to BSE, three of the four blood
transfusion-associated vCJD cases were reported in elderly pa-
tients. Two cases were preclinical and confirmed postmortem by
detection of PrPSc within secondary lymphoid tissues (18, 43).
However, a third case was reported as clinical vCJD in an elderly
patient 6.5 years after receiving a transfusion of red blood cells
from a vCJD-infected donor (28). Since the age of this patient was
substantially beyond that of themajority of the cases considered to
be acquired through dietary exposure (62 years at time of trans-
fusion with vCJD-contaminated red cells), this raises the pos-
sibility that intravenous (i.v.) exposure may be more efficient
in the elderly than other peripheral routes of exposure. To test
this hypothesis, groups of young mice (6 to 8 weeks old) and
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aged mice (600 days old) were injected i.v. with a TSE agent.
We show that, in aged mice as in young adult mice, the i.v.
route is more efficient than other peripheral routes of TSE
agent exposure (24). However, disease pathogenesis in i.v. ex-
posed agedmice was significantly impaired compared to that in
youngmice, with most failing to develop clinical disease during
their life spans. Cells within the marginal zone (MZ) of the
spleen play an important role in the capture of blood-borne
antigens and immune complexes and their efficient transport
to FDCs (7, 38). We show that the microarchitecture of the MZ
is disturbed in agedmice, significantly impairing the delivery of
immune complexes to FDCs. TSE agents are likewise consid-
ered to be acquired by FDCs as complement-bound complexes
(26, 30, 31, 50). Thus, these data imply that the impaired TSE
pathogenesis in aged mice after i.v. exposure is likewise a con-
sequence of the reduced transport of TSE agent-containing
complement-bound complexes from the MZ to FDCs.
MATERIALS AND METHODS
Mice. C57BL/Dk mice were aged to approximately 600 days under
specific-pathogen-free (SPF) conditions prior to exposure to the scrapie
agent. Six- to 8-week-old C57BL/Dk mice were used as young adults.
tga20mice overexpressing PrPc (15) weremaintained on aC57BL/6 back-
ground. Prnp/ mice were bred and maintained on a 129/Ola back-
ground (35). All experimental procedures were approved by The Roslin
Institute’s Ethical Review Committee and conducted according to the
strict regulations of the UKHome Office Animals (Scientific Procedures)
Act 1986.
Scrapie agent exposure and disease monitoring. For intracerebral
(i.c.) or intraperitoneal (i.p.) exposure, mice were injected with 20 l of a
1% (wt/vol) scrapie brain homogenate prepared from mice terminally
affected with theME7 scrapie agent strain (containing approximately 1
104 i.c. 50% infectious dose [ID50] units). For i.v. exposure, mice were
injected into the tail vein with 20 l of a 0.1% dilution of scrapie brain
homogenate. Following scrapie agent exposure,micewere coded, assessed
weekly for signs of clinical disease, and culled at a standard clinical end-
point. The clinical endpoint of disease was determined by rating the se-
verity of clinical signs of TSE disease exhibited by the mice. Following
clinical assessment, mice were scored as “unaffected,” “possibly affected,”
and “definitely affected” using standard criteria which typically present in
mice clinically affected with ME7 scrapie. Clinical signs for the ME7
scrapie agentmay include the following: weight loss, starry coat, hunched,
jumpy behavior (at early onset) progressing to limitedmovement, upright
tail, wet genitals, decreased awareness, discharge from eyes and/or blink-
ing eyes, and ataxia of hind legs. The clinical endpoint of disease was
defined in one of the following ways: (i) the day on which a mouse re-
ceived a second consecutive “definite” rating, (ii) the day on which a
mouse received a third “definite” rating within four consecutive weeks, or
(iii) the day on which a mouse was culled in extremis.
The following criteria were used to help distinguish between the clin-
ical signs of aging (senility) in mice from those of TSE disease. The fur of
agedmice may lose color and appear less sleek. Body shape may gradually
change. Senile mice may have a “vacant stare,” whereby the face looks
thinner and the eyes not as bright. Mice beginning to display clinical signs
of TSE disease move quicker and become more conspicuous, whereas
those displaying definite positive signs of scrapie are immobile and less
interactive with their cage mates. In contrast, senile mice still move
around their cages and interact with their cage mates.
Survival times were recorded for mice that did not develop clinical
signs of disease and were culled when they showed signs of intercurrent
disease. Scrapie diagnosis was confirmed by histopathological assessment
of vacuolation in the brain. For the construction of lesion profiles, vacu-
olar changes were scored in nine gray-matter areas of each brain, as de-
scribed previously (16). Where indicated, some mice were culled 35 and
70 days postinjection (dpi) with scrapie, and spleens were taken for fur-
ther analysis. For bioassay of scrapie agent infectivity, individual half-
spleens were prepared as 10% (wt/vol) homogenates in physiological sa-
line. Groups of four tga20 indicator mice were injected i.c. with 20 l of
each homogenate. The scrapie titer in each sample was determined from
the mean incubation period in the indicator mice, by reference to a dose/
incubation period response curve for ME7 scrapie-infected spleen tissue
serially titrated in tga20mice using the relationship: y 9.4533 0.0595x
(where y is log ID50 U/20 l of homogenate, and x is the incubation
period; R2 0.9562). As the expression level of cellular PrPc controls the
TSE disease incubation period, tga20 mice overexpressing PrPc are ex-
tremely useful as indicator mice in scrapie agent infectivity bioassays as
they succumb to disease with much shorter incubation times than con-
ventional mouse strains (15).
IHC. For the detection of disease-specific PrP (PrPd) in brains and
spleens, tissues were fixed in periodate-lysine-paraformaldehyde fixative
and embedded in paraffin wax. Sections (thickness of 6 m) were depar-
affinized and pretreated to enhance the detection of PrPd by hydrated
autoclaving (15 min, 121°C, hydration) and subsequent immersion in
formic acid (98%) for 5min (37). Sectionswere then immunostainedwith
1B3 PrP-specific polyclonal antiserum (13). For the detection of astro-
cytes, brain sections were immunostained with anti-glial fibrillary acidic
protein (anti-GFAP; Dako, Ely, United Kingdom). For the detection of
microglia, deparaffinized brain sections were first pretreated with Dako
target retrieval solution and subsequently immunostained with anti-
ionized calcium-binding adaptor molecule 1 (Iba-1; Wako Chemicals
GmbH, Neuss, Germany). Paraffin-embedded tissue (PET) immunoblot
analysis was used to confirm that the PrPd detected by immunohisto-
chemistry (IHC) was proteinase K (PK)-resistant PrPSc (44). Membranes
were subsequently immunostained with 1B3 PrP-specific polyclonal an-
tiserum.
To detect FDCs, frozen spleen sections (thickness, 10 m) were fixed
in acetone and visualized by staining with complement component C4-
specific rat monoclonal antibody (MAb) FDC-M2 (AMS Biotechnology,
Abingdon, United Kingdom) or MAb 8C12 to detect CR1 (CD35; BD
Biosciences PharMingen, CA). Cellular PrPc was detected using 1B3 PrP-
specific polyclonal antiserum. B cells were detected using monoclonal
antibody B220 to detect CD45R (Caltag Laboratories, Buckingham,
United Kingdom). Marginal zone (MZ) B cells were detected using MAb
1B1 to detect CD1d (BD Biosciences PharMingen). MZ sinus-lining cells
were detected using MAb MECA-367 (BD Biosciences PharMingen)
specific for mucosal vascular addressin cell-adhesion molecule 1
(MADCAM1). C-type lectin SIGNR1-expressing MZ macrophages were
detected using MAb ER-TR9 (BMA Biomedicals, Augst, Switzerland),
and sialic acid-binding immunoglobulin-like lectin 1 (SIGLEC1/CD169)-
expressing MZ metallophilic macrophages were detected using MAb
MOMA-1 (AdB Serotec, Kidlington, United Kingdom).
For lightmicroscopy, immunolabelingwas revealed using horseradish
peroxidase (HRP) conjugated to the avidin-biotin complex (Novared kit;
Vector Laboratories, Peterborough, United Kingdom). For fluorescence
microscopy, following the addition of primary antibodies, species-specific
secondary antibodies coupled to Alexa Fluor 488 (green), Alexa Fluor 594
(red), and Alexa Fluor 647 (blue) dyes (Invitrogen Life Technologies)
were used.
Quantitative real-time PCR analysis ofPrnpmRNA expression.To-
tal RNA was isolated from coded mouse brain (comprising the thalamus,
hippocampus, and lateral cortex areas) samples using the RNeasy lipid
tissue kit (Qiagen, Crawley, United Kingdom) followed by treatment with
DNase I (Ambion, Warrington, United Kingdom). First-strand cDNA
synthesis was performed using 1 g of total RNA and Superscript III
reverse transcriptase as described by the manufacturer (Invitrogen, Pais-
ley, United Kingdom). Real-time quantitative PCR (qPCR) amplification
was carried out in 10-l reactions using FastStart Taq DNA polymerase
(Roche, Burgess Hill, United Kingdom) and SYBR green I detection. The
Prnp primers used were forward (5=-TCCAATTTAGGAGAGCCAAGC-
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3=) and reverse (5=-GCCGACATCAGTCCACATAG-3=); the reference
gene primers were SSDHA, YWHAZ, GAPDH, RPL13A, and CALNX
from the Quantace mouse normalization gene panel (Quantace, London,
United Kingdom). After evaluation using the geNorm application (47),
the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and SSDHA
genes were chosen as the most stable reference genes for normalization.
The PCR conditions used were 5 min at 94°C, followed by 40 cycles of 20
s at 94°C, 20 s at gene-specific annealingmelting temperature (Tm), and 20
s at 72°C, followed by a dissociation curve analysis program. Data were
analyzed using Rotor-Gene 3000 software (version 6.1.93; Corbett Life
Science).
Quantitative real-timePCRanalysis ofC4bmRNAexpression.Total
RNAwas isolated from codedmouse liver samples using the RNeasy lipid
tissue kit (Qiagen, Crawley, United Kingdom) followed by treatment with
DNase I (Ambion, Warrington, United Kingdom). First-strand cDNA
synthesis was performed using 1 g of total RNA and Superscript III
reverse transcriptase (SuperScript VILO cDNA synthesis kit) as described
by the manufacturer (Invitrogen, Paisley, United Kingdom). PCR ampli-
fication reactions were carried out in 25-l reaction mixtures using a
Rotor-Gene SYBR green PCR kit (Qiagen, United Kingdom). All qPCR
primers used were QuantiTect primer assays designed and purchased
fromQiagen, for complement component 4B (QT01782011) and the ref-
erence gene, the primers usedwere eukaryotic translation initiation factor
2a (QT01050735), hypoxanthine guanine phosphoribosyl transferase
(QT00166768), peptidylprolyl isomerase B (QT00169736), 18S rRNA
(QT01036875), and ribosomal protein, large, P0 (QT00249375). After
evaluation using the geNorm application (48),Hprt and Ppibwere chosen
as the most stable reference genes for normalization. The PCR conditions
used were 5 min at 95°C, followed by 40 cycles of 5 s at 95°C and 15 s at
60°C, followed by a dissociation curve analysis program. Data were ana-
lyzed using Rotor-Gene 3000 software (version 6.1.93; Corbett Life Sci-
ence), and statistical differences were assessed with a nonparametric
Mann-Whitney U test (two-tailed probabilities) using GraphPad Prism
version 5.04 (GraphPad Software).
Plasma C4 analysis. Blood from mice from each group was collected
into sterile EDTA-treated containers and immediately centrifuged at
1,000  g for 20 min at 4°C. Plasma was collected and stored at 80°C
prior to use. Plasma C4 concentrations were measured using a mouse
complement component 4 enzyme-linked immunosorbent assay (ELISA)
kit (Unsc Life Science, Inc.,Wuhan, China) according to themanufactur-
er’s instructions.
In vivo immune complex trapping. To assess antigen trapping by
FDCs in vivo, mice were passively immunized by i.p. injection with 100l
preformed peroxidase-antiperoxidase (PAP) immune complexes
(Sigma). Spleens were removed 48 h later, and the levels of FDC-
associated immune complexes compared by IHC. Digital microscopy im-
ages were analyzed using ImageJ software (http://rsb.info.nih.gov/ij/), as
described previously (22). Spleens from 6 mice from each group were
analyzed. From each spleen, 4 sections were studied, and on each section,
data from 3 randomly chosen 1,000- by 1,000-m fields of view were
collected.
Embryonic spleen transplantation. Developing whole embryonic
day 15 spleens from Prnp/ or wild-type control mice were collected
using a dissecting microscope and grafted under the kidney capsule of
recipient wild-type mice (5 weeks old) as described previously (17). Re-
cipient mice were culled 6 weeks later, and grafted spleens were collected
and analyzed by IHC.
Statistical analysis.Differences in the incidence of clinical disease and
vacuolar pathology were compared between age groups within each ex-
posure route using Fisher’s exact test for 2-by-2 contingency tables (49).
Brain lesion scores in animals with positive vacuolar pathology were com-
pared between ageswithin each exposure route usingmultivariate analysis
of variance (6).
RESULTS
Effect of host age on susceptibility to i.v. injected scrapie.When
young adult (6 to 8 weeks old) and aged (600 days old)
C57BL/Dk mice were injected i.c. with the ME7 scrapie agent
strain, no significant differences in disease incidence, the onset of
clinical signs, or incubation period of disease were observed (P
0.92, Fisher’s exact test). The i.c. injectedmice succumbed to clin-
ical disease approximately 165 days after exposure (young, 163
3 days, n 5/6; aged, 167 8 days, n 6/7), clearly demonstrat-
ing that aging has no effect on TSE disease susceptibility when the
infection is established directly in theCNS. In contrast, whenmice
were injected i.v. with the scrapie agent, a significant effect of host
age on the incidence of clinical disease was observed (P  0.001,
Fisher’s exact test). All young i.v. injected mice succumbed to
clinical disease, with a mean incubation period of 222  7 days
(n  9/9). In contrast, only 5 of 16 i.v. injected aged mice suc-
cumbed to clinical disease during their life spans, with individual
incubation periods ranging from216 to 324 days (Table 1). Due to
the advanced ages of the aged mice used in this study, some were
culled due to aging-related intercurrent disease, including senility,
swollen abdomen, eye abscess, etc. Six of these mice were culled at
times after exposure prior to the arrival and detection of the TSE
agent within the brains of the i.v. injected young mice (individual
survival times of 120, 120, 127, 134, 141, and 148 days). No vacu-
olar pathology or PrPd was detected in any of the brains from the
mice culled148 days postinjection. As a consequence, only the
clinically negative aged mice that were culled after the first clini-
cally positive, pathologically confirmed case in the young mouse
group were included in our analysis (representing mice ranging
from190 to 317 days after scrapie exposure, whichwere 790 to 917
days old).
We next compared the susceptibility of aged mice to TSE in-
fection via the i.v., i.p., or oral routes using data derived from two
independent sets of experiments (Table 2). These data show that
even though the i.p. injected aged mice were given a 10 higher
dose of the TSE agent compared to the i.v. injected mice (i.p.
route, 20l of 1.0% scrapie brain homogenate; i.v. route, 20l of
0.1% scrapie brain homogenate), only 1/21 i.p. injected mice suc-
cumbed to clinical disease during their life spans (Table 2). None
of the aged mice developed clinical disease after oral exposure to
the scrapie agent. Together, these data show that although as in
young mice the i.v. route is more efficient than other peripheral
routes of TSE agent exposure in aged mice (24), disease suscepti-
bility is significantly reduced compared to that in young mice.
Effect of host age on the development of neuropathological
changes.Histopathological analysis of brain tissue from all of the
clinically affected, i.c. injected, young and aged mice showed the
characteristic spongiform pathology, astrogliosis, microgliosis,
and disease-specific PrP (PrPd) accumulation associated with ter-
minal TSE disease (Fig. 1A). The brains from all the clinically
affected i.v. injected, young and aged mice likewise displayed the
typical TSE-specific neuropathological changes and PrPd accu-
mulation associated with infection with the ME7 scrapie agent
strain (Fig. 1B, left-hand columns). Paraffin-embedded tissue
(PET) immunoblot analysis can be used to demonstrate the pres-
ence of TSE agent-specific PrPSc on histological sections (44).
During the tissue processing, sections are treated with PK to de-
stroy the cellular PrPc, leaving only the PK-resistant PrPSc (if pres-
ent). PET immunoblotting confirmed that the PrPd detected by
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immunohistochemistry within the brains of all of the clinically
affected, i.v. injected, young and agedmice was TSE agent-specific
PrPSc (Fig. 1B, panels q and r, respectively). In contrast, the ma-
jority (8/11) of the brains from the clinically negative aged mice
did not show signs of spongiform pathology (Table 1) and had
negligible levels of reactive astrocytes and microglia (Fig. 1B,
right-hand columns). However, most (9/11) of the clinically neg-
ative aged mice displayed evidence of PrPSc accumulation in their
brains (Table 1), which was typically restricted to a few small foci
(Fig. 1B, panels o and s).
Spongiform vacuolation of the neuropil is a neuropathological
characteristic of TSE infection. Although both young and aged
mice succumbed to clinical TSE disease with similar incubation
periods after i.c. exposure, the magnitude of the spongiform pa-
thology was significantly lower in aged mice than that in young
mice (Fig. 2A) (P 0.05, multivariate analysis of variance). Sim-
ilarly, the average severity of the spongiform pathology within the
brains of the clinically affected, i.v. injected aged mice also was
significantly lower than that observed in young mice (Fig. 2B)
(P 0.01, multivariate analysis of variance). The reasons for the
reduced spongiform pathology in the brains of the clinically af-
fected aged mice are not known. To determine whether this was
due to the influence of host age on PrPc expression in the brain, we
compared Prnp transcript levels in tissues from young and aged
mice by quantitative real-time PCR analysis. No significant differ-
ences in Prnp transcript levels were observed between brains from
young or aged mice (Fig. 2C) (P  0.776, Mann-Whitney test),
clearly demonstrating that the effects of host age on the reduced
spongiform pathology and reduced susceptibility to i.v. injected
scrapie were not due to effects on Prnp expression levels in the
brain.
The effect of host age on scrapie agent accumulation in the
spleen. Following peripheral exposure, the early accumulation of
TSE agents upon FDCs in the secondary lymphoid tissues is a
crucial stage in the neuroinvasion process (32, 34, 39). Heavy PrPd
accumulations, consistent with localization upon FDCs, were de-
tected immunohistochemically in the spleens of all young adult
mice at 5 and 10 weeks after i.v. injection with the scrapie agent
(Fig. 3A and B, upper panels) and were maintained until the ter-
minal stages of disease (Table 1). PET immunoblotting confirmed
TABLE 1. Effect of host age on susceptibility to i.v. scrapie infection
Mouse model and incubation period/survival timea Clinical disease
Vacuolar pathology
in brainb
PrPd in:
Brainc Spleen
Young
Incubation period (days)
190, 197, 216, 216, 216, 225, 239, 239, 260 Yes (9/9 mice) Yes (9/9 mice) Yes (9/9 mice) Yes (9/9 mice)
Aged
Incubation period (days)
216 Yes Yes Yes Yes
255 Yes Yes Yes Yes
274 Yes Yes Yes No
317 Yes Yes Yes Yes
324 Yes Yes Yes No
Survival time (days)
232 No Yes Yes Yes
285 No Yes Yes Yes
293 No Yes Yes Yes
190 No No Yes Yes
197 No No Yes No
225 No No Yes No
232 No No Yes No
232 No No No No
246 No No Yes NDe
291 No No No No
317 No No Yes No
Incidence (no. of mice affected/no. tested)d 5/16 (P 0.001) 8/16 (P 0.05) 14/16 7/15
a Young C57BL/Dk mice were 6 to 8 weeks old at the time of i.v. scrapie agent exposure. Aged C57BL/Dk mice were600 days old at the time of i.v. scrapie agent exposure. Only
aged mice that were culled after the first clinically positive case in the corresponding group of young mice (190 days postinjection) were included in the analysis. Six aged mice were
culled190 days postinjection (individual survival times of 120, 120, 127, 134, 141, and 148 days). No vacuolar pathology or PrPd was detected in any of the brains from the mice
culled190 days postinjection. The mean standard error of the mean (SEM) disease incubation period for young mice was 222 7 days.
b The magnitude of the TSE-specific vacuolation was scored using a scale of 0 to 5 in 9 distinct gray matter areas as described previously (16). A score of 1 (a small number of
vacuoles) or greater in any region of the brain was considered positive.
c The detection of PrPd in any region on the tissue section was considered positive.
d Only aged mice that were culled after the first clinically positive case in the corresponding group of young mice were included in the analysis. Statistical differences in the
incidence of clinical disease and vacuolar pathology in the brain were compared between age groups with Fisher’s exact test for 2-by-2 contingency tables.
e ND, not determined.
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the presence of TSE agent-specific PrPSc upon the surfaces of the
FDCs in spleens from youngmice (Fig. 3A andB, lower panels). In
contrast, in aged spleens PrPSc was only detected in 1 of 2 spleens
at 5 weeks postinfection (Fig. 3A). Similarly, the same spleens
from the young adult mice collected 5 weeks postinfection con-
tained high levels of scrapie agent infectivity (5.6 and 6.3 log ID50
U/g, respectively). However, only one of the aged spleens con-
tained high levels of scrapie agent infectivity (5.4 log ID50U/g); the
other contained at least 100 less agent infectivity than that mea-
sured in the young spleens (3.4 logID50 U/g). By 10 wk after i.v.
exposure, PrPSc was detected in both aged spleens, although in one
of the samples, the PrPSc was only observed in association with a
single FDC network (Fig. 3B).
Following peripheral exposure of young mice to the ME7
scrapie agent, strong levels of PrPSc accumulations aremaintained
upon the surfaces of FDCs for the duration of disease (33 and 34).
However, when we analyzed spleens from aged mice taken at the
end of the experiment (from both clinically scrapie-affected and
clinically negativemice), considerable variation in the detection of
PrPSc was observed (Table 1). Despite the presence of PrPSc in the
brains ofmostmice, inmany spleens, PrPSc was undetectable, and
in twomice, PrPSc was observable only upon occasional FDC net-
works.
The retention of complement component C4 and expression
ofPrPcuponFDCs is impaired in the spleensof agedmice.FDCs
characteristically trap and retain native antigen on their surfaces
in the form of immune complexes, consisting of antigen-antibody
and/or opsonizing complement components.Whereas high levels
of complement component C4 and cellular PrPc were expressed
on the surfaces of FDCs from young mice, this was severely re-
duced on most FDC networks in the spleens of aged mice (Fig.
4A). Morphometric analysis confirmed that the magnitude of
complement component C4 retained upon FDCs in the spleens of
aged mice was significantly reduced compared to that in young
mice (Fig. 4B) (P 0.0025; n 36 fields of view/group). FDCs in
mice characteristically express high levels of complement receptor
1 (CR1/CD35) (34, 50). However, whenwe compared the levels of
expression of CR1/CD35 by FDCs, similar levels were detected in
the spleens of both young and aged mice (Fig. 4C). Since the ex-
pression of CD35 by aged FDCs appeared to be unaffected, we
next compared complement component C4 levels between each
mouse group to determine whether expression was reduced in
aged mice. The comparison of C4bmRNA expression (which en-
codes C4 in the mouse) across 95 individual microarray data sets
representing a wide range of mouse tissues and cell-lineages
clearly shows that the liver is the major source of complement
component C4 (see Fig. S1A in the supplemental material; http:
//biogps.gnf.org). The levels ofC4b expressed by FDCs themselves
are negligible in comparison (see Fig. S1B). We therefore com-
pared C4b transcript levels in livers from young and aged mice by
quantitative real-time PCR analysis. No significant difference in
C4b transcript levels were observed between livers from young or
aged mice (Fig. 4D) (P  0.286, Mann-Whitney test). Similarly,
the synthesis of C4 was not adversely affected as no significant
difference was observed in plasma C4 levels between young and
aged mice (Fig. 4E) (P  0.191, Student’s t test). We also com-
pared the transcriptional profiles of other complement
component-encoding genes (C1qa, C1qb, C1qc, C1r, C1s, C1qbp,
C3, Cfh, and Cfi) across a large microarray data set of livers from
aging C57BL/6 mice (age range, 29 to 722 days old; n 40) (51).
Consistent with our data for C4b expression (Fig. 4D), which was
not represented on themicroarrays used (51), no significant effect
of aging on the expression of any of these genes in the liver was
observed (see Tables S1 and S2 in the supplemental material).
These data clearly demonstrate that the effects of host age on
C4 retention by FDCs were not due to effects on the synthesis of
opsonizing complement components. Instead, these data imply
that the ability of aged FDCs to trap and retain C4-containing
immune complexes was adversely affected.
Host cells must express cellular PrPC to replicate TSE agents
(35), and FDCs appear to express high levels of PrPC on the cell
membrane in uninfected mice (3, 25). Many cell types secrete
small membrane vesicles termed exosomes that are enriched in
cell-specific protein (11, 14). These microvesicles enable FDCs to
passively acquire and display proteins on their surfaces that they
do not express at the mRNA level (12). To determine whether
FDCs likewise passively acquire significant levels of PrPC from
other cell lineages, whole embryonic day 15 spleen tissue from
PrPC-deficient (Prnp/) mice or wild-type (WT) controls was
transplanted under the kidney capsule of WT recipient mice (17).
TABLE 2. Effect of route of exposure on TSE disease susceptibility in aged mice
Expta
Route of
exposure
Disease incubation period or
survival timeb
% inoculum
dilution
(wt/vol)
Clinical disease incidence
(no. of mice affected/no.
tested)b
No. of mice affected/no. tested
Vacuolar pathology
in brain PrPd in brain
Expt 1 i.v. Incubation periods, 216, 255, 274, 317,
and 324 days
0.1 5/16 8/16 14/16
Survival time, 190–317 days
i.p. Incubation period, 321 days 1.0 1/12 3/12 9/10c
Survival time, 230–357 days
Expt 2 i.p. Survival time, 247–323 days 1.0 0/9 3/9 6/9
Oral Survival time, 282–366 days 1.0 0/12 5/12 12/12
a Experiment 1 represents the present study; experiment 2 represents data from Brown et al. (4). Young C57BL/Dk mice were 6 to 8 weeks old at the time of scrapie agent exposure.
Aged C57BL/Dk mice were600 days old at the time of scrapie agent exposure.
b Only aged mice that were culled after the first clinically positive case in the corresponding group of young mice were included in the analysis.
c Two brains were unavailable for PrPd analysis.
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Sixweeks after transplant, recipient kidneyswere collected and the
grafted spleen tissue was analyzed by IHC. Within the grafted
spleens, the stromally-derived FDCs are of the donor Prnp geno-
type, whereas the majority of the hematopoietically derived cells
(lymphocytes, macrophages, etc.) within the graft and all cell lin-
eages within the rest of themouse are of the host Prnp genotype. If
FDCs do acquire PrPC from other cell lineages, one would expect
to detect PrPC upon the surfaces of the FDCs within the PrPC-
deficient spleens grafted intoWTmice (Prnp/¡WT). As antic-
ipated, FDCs expressing high levels of PrPC were detected in the
B-cell follicles of theWTdonor spleens grafted intoWT recipients
(WT¡WT; Fig. 4F). However, no PrPC was detected upon FDCs
within the Prnp/ spleens grafted intoWTmice (Prnp/¡WT;
Fig. 4F). These data therefore confirm that FDCs express high
levels of PrPC and do not simply acquire it from other cell popu-
lations. Taken together, these data suggest that the expression of
PrPC by FDCs themselves is considerably reduced in the spleens of
aged mice.
The abilities of FDCs to retain complement-bound complexes
and express high levels of PrPc are both considered important for
the trapping and amplification of TSE agents upon their surfaces
(3, 25, 26, 30, 31, 50). Data in the present study clearly show that
both of these properties are dramatically impaired in the spleens
of aged mice.
The effects of host age on the splenic marginal zone impair
immune complex trapping byFDCs.Ourdata show that the abil-
ity of FDCs to retain complement-bound immune complexes was
impaired in the spleens of agedmice despite the expression of high
levels of CR1 on their surfaces. Therefore, we next investigated
whether the transport of immune complexes to FDCs in the
spleens of agedmice was adversely affected. Blood-borne antigens
enter the spleen via the sinus of the marginal zone (MZ), where
they are rapidly cleared by macrophages. Within the MZ, a spe-
cialized subset of B cells also plays an important role in the capture
of immune complexes and facilitates their delivery to FDCs (7).
We determined whether aging adversely affected the microarchi-
tecture of theMZ and, as a consequence, systemic antigen capture
and delivery to FDCs. In the spleens of young mice, a distinct
channel of sinus-lining cells expressing mucosal vascular ad-
dressin cell-adhesion molecule 1 (MADCAM1) forms a barrier
FIG 1 Effect of host age on the development of neuropathology with the brain
at the terminal stage of disease. (A) Histopathological analysis of brains from
clinically scrapie-affected young and aged mice infected with the scrapie
agent introduced directly into the brain by i.c. injection. (B)Histopathological
analysis of brains fromyoung and agedmice exposed to the scrapie agent by i.v.
injection: panels a to d, spongiformpathology; panels e to h, reactive astrocytes
expressing GFAP (brown); panels i to l, Iba-1-expressing microglia (brown);
panels m to p, disease-specific PrP (PrPd; brown); panels q to t, PET immuno-
blot detection of PK-resistant PrPSc (blue or black). High levels of spongiform
pathology, reactive astrocytes expressing GFAP, and active microglia express-
ing Iba-1 and large accumulations of PrPd/PrPSc were detected in the hip-
pocampi of the brains of all clinically scrapie-affected young and aged mice
(left-hand columns). In contrast, most brains from the i.v. injected, clinically
negative agedmice did not show signs of spongiform pathology, and the levels
of astrocytosis (g and h) and microgliosis (k and l) were likewise reduced in
comparison to brains from mice with clinical disease (e and f and i and j,
respectively). However, most of the brains from the clinically negative aged
mice displayed evidence of PrPd/PrPSc deposition, which was typically re-
stricted to a few small foci such as the thalamus (arrows, panel o). Scale bar in
panels a to n and p, 20m; scale bar in panels q to t, 50m. Panel o shows the
thalamus as no PrPSc accumulation was detected in the hippocamus. Scale bar,
20m.H&E, hematoxylin and eosin; Clin., presence of clinical signs of scrapie
at the time of cull; Path., detection of spongiform pathology in the brain; dpi,
days postinjection with the scrapie agent.
Brown et al.
30 jvi.asm.org Journal of Virology
between the MZ and the white pulp (Fig. 5A). Two distinct pop-
ulations of macrophages also reside in the MZ. Within an outer
layer are a ring of C-type lectin SIGNR1-expressing MZ macro-
phages, and in a continuous inner ring close to the white pulp are
the sialic-acid-binding immunoglobulin-like lectin 1 (SIGLEC1/
CD169)-expressing MZ metallophilic macrophages (38) (Fig.
5A). IHC analysis of the MZmicroarchitecture within the spleens
of aged mice revealed that the distribution and density of the
MAdCAM1-expressing sinus-lining cells, MZ macrophages, and
MZ metallophilic macrophages were all severely disrupted com-
pared to those of young mice (Fig. 5A, right-hand panels).
In mice, the MZ B cells can be readily discriminated by their
expression of high levels of the nonclassical major histocompati-
bility complex molecule CD1d (7, 36). In the spleens of young
mice, abundant CD1d-expressing MZ B cells were present within
the MZ and B-cell follicles, whereas in the spleens of aged mice,
their distribution appeared disrupted (Fig. 5B). Since the shuttling
of MZ B cells between the MZ and B-cell follicles provides an
efficient mechanism for the delivery of systemic antigen to FDCs
(7), we reasoned that the disruptedMZmicroarchitecture in aged
mice might impair immune complex trapping by FDCs. To test
this hypothesis, mice were passively immunized with preformed
PAP immune complexes, and 48 h later, the presence of FDC-
associated immune complexes was identified by IHC. Consistent
with our observation of reduced complement component C4 ac-
cumulation upon aged FDCs (Fig. 4A and B), the magnitude of
immune complex trapping detected upon FDCs in the spleens
of aged mice was also significantly reduced compared to that of
youngmice (Fig. 5C andD) (P 0.014;n 40/group). These data
clearly show that the effects of host age on themicroarchitecture of
the splenic MZ significantly impair the delivery and retention of
immune complexes upon FDCs. TSE agents are likewise consid-
FIG 2 Effect of host age on TSE-specific neuropathology and Prnp expression
in the brain. (A and B) Pathological assessment of the spongiform change
(vacuolation) in the brains of young (closed circles) and aged (open circles)
micewith positive vacuolar pathology after i.c. (A) or i.v. (B) injectionwith the
scrapie agent. Vacuolation was scored on a scale of 1 to 5 in nine gray matter
areas: 1, dorsal medulla; 2, cerebellar cortex; 3, superior colliculus; 4, hypo-
thalamus; 5, thalamus; 6, hippocampus; 7, septum; 8, retrosplenial and adja-
cent motor cortex; 9, cingulate and adjacent motor cortex. Each point repre-
sents the mean vacuolation score  standard error of the mean (SEM) for
groups of 5 to 9 mice. The severity of the vacuolar pathology was significantly
lower in the brains of aged mice (A, P 0.05, n 5 young, n 6 aged; B, P
0.01, n  9 young, n  5 aged; multivariate analysis of variance). (C) Prnp
transcript levels in the brains of young and old mice. Real-time RT-qPCR
analyses were performed on samples from brains of young (n  6) and aged
(n 8) mice. No significant difference in Prnp transcript levels were observed
between the two age groups of mice (P 0.776, Mann-Whitney test).
FIG 3 Effect of host age on TSE agent accumulation in the spleen. High levels
of PrPd (red, upper rows) were detected in association with FDCs in spleens
from young mice at 5 weeks (A) and 10 weeks (B) after i.v. injection with the
scrapie agent. Analysis of adjacent sections by PET immunoblot analysis con-
firmed the presence of PK-resistant PrPSc (blue or black, lower rows). In con-
trast, PrPSc was only detected in 1 of 2 aged spleens at 5 weeks postinfection
(B). At 10 weeks after i.v. injection, PrPSc was detected in both aged spleens,
although in one, the PrPSc was only detected in association with a single FDC
network (B, far-right column). Arrows indicate sites of PrPSc accumulation
upon FDCs. Upper rows, scale bar, 20 m; lower rows, scale bar, 50 m.
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FIG 4 Effect of host age on FDC status. (A) Triple immunofluorescent analysis of FDC status. High levels of complement component C4 (blue) and cellular PrPc
(red) were expressed on the surfaces of FDCs within the B-cell follicles (B cells, CD45R, green) of youngmice (left-hand panels). In contrast, on the FDCs in the
spleens of aged mice, the detection of complement component C4 and cellular PrPc was dramatically reduced (right-hand panels). Scale bar, 20 m. (B)
Morphometric analysis confirmed that the level of complement component C4 colocalized upon the surfaces of FDCs in spleens of aged mice was significantly
lower than that observed in spleens from youngmice (P 0.0025, n 36 fields of view/group). (C) Comparison of complement receptor 1 (CR1/CD35; brown)
expression upon young and aged FDCs. Scale bar, 20 m. (D) Real-time RT-qPCR analysis of C4b transcript levels in livers of young and old mice (n 5 and
4/group, respectively). No significant differences in transcript levels were observed between the two age groups of mice (P  0.286, Mann-Whitney test). (E)
ELISA analysis revealed no significant difference in the complement component C4 concentration in plasma from young and aged mice (Fig. 4D) (P 0.191,
Student’s t test). (F) FDCs do not passively acquire significant levels of PrPC from other cell types. Whole embryonic day 15 spleen tissue from Prnp/mice or
wild-type (WT) controls was transplanted under the kidney capsule of WT recipient mice. Grafted spleens were analyzed 6 weeks after transplant. FDCs
expressing high levels of PrPC were detected in the B-cell follicles of the WT donor spleens grafted into WT recipients (WT¡WT; left-hand panels). However,
no PrPC was detected upon FDCs within the Prnp/ spleens grafted intoWTmice (Prnp/¡WT; right-hand panels). Upper panels, scale bar, 200m; lower
panels, scale bar, 50 m.
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ered to be initially acquired by FDCs as complement-bound com-
plexes (26, 30, 31, 50). Thus, these data imply that the impaired
scrapie pathogenesis in aged mice after intravenous exposure is
likewise a consequence of the reduced transport of TSE agent con-
taining complement-bound complexes from the MZ to FDCs.
DISCUSSION
Here we show that in aged mice as in young adult mice (24), the
i.v. route is more efficient than other peripheral routes of TSE
agent exposure. However, disease pathogenesis in i.v. exposed
aged mice is significantly impaired compared to that in young
mice, with most failing to develop clinical disease during their life
spans.While multiple factors may contribute to the effects of host
age on TSE susceptibility, we consider the major influence is most
likely due to disturbances to the microarchitecture of the splenic
MZ which adversely affect the transport and deposition of im-
mune complexes on FDCs. As a consequence, the ability of FDCs
to trap and accumulate complement-bound TSE agents after i.v.
exposure may also be dramatically reduced, impairing disease
pathogenesis. This hypothesis is consistent with the demonstra-
tion that aging had no effect on Prnp expression in the brain or
TSE disease incubation period and susceptibility when the infec-
FIG 5 Effect of host age on the microarchitecture of the splenic MZ. (A) In the spleens of young mice, MADCAM1-expressing sinus-lining cells form a barrier
between the MZ and the white pulp (WP) (brown, arrows). RP, red pulp. Two distinct populations of macrophages also reside in the MZ: SIGNR1-expressing
MZmacrophages and SIGLEC1/CD169-expressingMZmetallophilic macrophages (middle and lower panels, respectively; brown). In the spleens of aged mice,
the distribution and density of the MAdCAM1-expressing sinus-lining cells, MZ macrophages, and MZ metallophilic macrophages were all severely disrupted
compared to those in youngmice (right-hand panels). Scale bar, 100m. (B) In the spleens of youngmice, abundant CD1d-expressingMZB cells (upper panels,
green, arrow; lower panels, brown, arrow) were present within the MZ and B-cell follicles (Fol). In the spleens of aged mice, the distribution of MZ B cells
appeared disrupted. Upper panel, scale bar, 50m; lower panel, scale bar, 100m. (C)Micewere passively immunizedwith preformed PAP immune complexes,
and 24 h later, the presence of immune complexes (green) upon FDCs (CR1/CD35 cells, red) was assessed by IHC. Scale bar, 50m (n 6 spleens/group). (D)
Morphometric analysis confirmed that the level of immune complexes colocalized upon the surfaces of FDCs in spleens of agedmice was significantly lower than
that observed in spleens from young mice (P 0.014).
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tion was established directly in the CNS. Indeed, previous data
show that the requirement for amplification upon FDCs prior to
neuroinvasion is bypassed when the TSE agent is injected directly
into the brain (3, 32–34).
However, some aged mice did develop clinical disease, and the
majority showed evidence of PrPSc in their brains. We cannot
exclude the possibility that if thesemice had survivedmuch longer
they all would have eventually developed clinical disease, but it is
important to note that the clinically negative i.v. injected mice
were between 790 and 917 days old when they were culled. Al-
though the MZs in the majority of the spleens of the aged mice
were severely disrupted, and their FDCs lacked PrPc expression
and displayed a reduced capacity to retain complement-
opsonized immune complexes, small numbers of intact PrPc-
expressing FDCnetworks were observed.Whenwemeasured TSE
agent accumulation in the spleens of aged mice, the levels were
variable. For example, one aged spleen contained at least 100 less
agent infectivity than that observed in young mice. After periph-
eral exposure, many host factors will aid the elimination of the
initial inoculum from the host. Following oral exposure, much of
the inoculum will be excreted or digested by enzymes in the gas-
trointestinal tract. After i.v. exposure, it is plausible that a larger
proportion of the initial inoculum is delivered intact to the spleen
to establish infection upon FDCs. Thus, the few remaining PrPC-
expressing FDCs in the spleens of the aged mice at the time of
exposure were most likely sufficient to eventually amplify the TSE
agent above the threshold required for neuroinvasion, causing
clinical disease in a small number of mice but extending the dis-
ease incubation period in most instances beyond the life span of
the mouse.
Despite the evidence of PrPSc accumulation in the brains of
most i.v. injected aged mice at the end of the experiment, its pres-
ence in the spleens of the same mice was variable. Our data imply
that in aged mice, the TSE agent initially accumulated upon the
remaining PrPC-expressing FDCs, facilitating subsequent neuro-
invasion (albeit at a much slower rate than in young mice), but
was most likely later cleared from the spleen by macrophages as
the status of the FDCs declined. The lack of direct correlation
between the presence of PrPSc in the brain and spleen of the i.v.
injected aged mice has important practical implications as there
are currently no reliable TSE-specific preclinical diagnostics avail-
able. The detection of PrPSc in lymphoid tissue biopsy specimens
such as tonsils and appendix has been proposed as a useful pre-
clinical assay to help predict the incidence of vCJD infection in the
human population (8, 10, 20, 23). However, as PrPd was absent in
the spleens of many i.v. injected aged mice, despite its presence in
the brains of the same animals, these data suggest that tests based
on the detection of the TSE agent in lymphoid tissues may be
much less sensitive when used on samples from aged individuals.
MZ B cells continuously shuttle between the MZ and B-cell
follicles and play an important role in the capture and transport of
blood-borne, complement-bound antigens to FDCs (7, 36). Our
data show that aging adversely affected the MZmicroarchitecture
and as a consequence substantially reduced the delivery of im-
mune complexes to FDCs. TSE agents are likewise considered to
be initially acquired by FDCs as complement-bound complexes
(26, 30, 31, 50). These data suggest the effects of aging on i.v. TSE
pathogenesis are most likely due to the reduced transport of
complement-opsonized TSE agents from the MZ to FDCs. The
mechanisms bywhich aging affects the status of the splenicMZare
not known. B cells play an important role in the organization and
maintenance of the MZ (9, 41, 46). Whether aging adversely af-
fects the expression of chemokines and cytokines, such as lympho-
toxins (46), which influence the expression of adhesionmolecules
by reticular fibroblasts and MZ sinus-lining cells remains to be
determined.
Our data show that FDCs express high levels of PrPC and do
not simply passively acquire it fromother cell types—for example,
via exosomes, which have been shown to permit intercellular
transfer of both PrPC and PrPSc (14). In the spleens of aged mice,
most FDCs lacked expression of PrPC. The aging-related factors
responsible for the downregulation of PrPC expression by FDCs
are uncertain. Data suggest that PrPC expression by FDCs is up-
regulated by immune complex trapping (29). In the absence of
complement component C1q, the upregulation of PrPC could not
be provoked. The reduced expression of PrPC by aged FDCs may
likewise be a consequence of their dramatically reduced ability to
trap complement-opsonized immune complexes. Of course, we
cannot exclude the possibility that the reduced expression of PrPC
and C4 on FDCs was in part due to death of a fraction of the aged
FDCs.However, our analysis of CD35 (CR1) expression suggested
no observable difference in the density of the FDCs between the
two aged groups.
In conclusion, we show that in aged mice as in young adult
mice, the i.v. route ismore efficient than other peripheral routes of
TSE agent exposure.However, disease pathogenesis in i.v. injected
aged mice is significantly impaired compared to that in young
mice, with most failing to develop clinical disease during their life
spans. Together, these data suggest that the effects of age on the
pathogenesis of i.v. TSE infection may lead to significant levels of
subclinical TSE disease in the population. Our data suggest that
the impairedTSEpathogenesis in the spleens of agedmice after i.v.
exposure is most likely a consequence of aging-related distur-
bances in the MZ that dramatically impair the transport of
complement-opsonized TSE agents from the MZ to FDCs. This
study is the first to show that the effects of aging on the micro-
architecture and function of the splenicMZ significantly influence
the pathogenesis of an important pathogen.
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